Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs UNICHEM LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH UNICHEM LAB PANACEA BIOTECH/
UNICHEM LAB
 
P/E (TTM) x -60.9 236.1 - View Chart
P/BV x 0.9 1.4 62.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PANACEA BIOTECH   UNICHEM LAB
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
UNICHEM LAB
Mar-23
PANACEA BIOTECH/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs191467 41.0%   
Low Rs107226 47.4%   
Sales per share (Unadj.) Rs75.1190.7 39.4%  
Earnings per share (Unadj.) Rs-5.5-28.7 19.2%  
Cash flow per share (Unadj.) Rs0.9-12.6 -7.0%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs137.7344.2 40.0%  
Shares outstanding (eoy) m61.2570.41 87.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.8 109.4%   
Avg P/E ratio x-27.1-12.1 224.6%  
P/CF ratio (eoy) x170.0-27.5 -618.6%  
Price / Book Value ratio x1.11.0 107.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m9,14224,396 37.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2653,564 35.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,59913,430 34.2%  
Other income Rs m517385 134.1%   
Total revenues Rs m5,11613,815 37.0%   
Gross profit Rs m47-841 -5.6%  
Depreciation Rs m3911,134 34.5%   
Interest Rs m44173 25.6%   
Profit before tax Rs m128-1,764 -7.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m466259 180.0%   
Profit after tax Rs m-337-2,022 16.7%  
Gross profit margin %1.0-6.3 -16.3%  
Effective tax rate %363.5-14.7 -2,478.8%   
Net profit margin %-7.3-15.1 48.7%  
BALANCE SHEET DATA
Current assets Rs m5,62315,885 35.4%   
Current liabilities Rs m3,2976,396 51.6%   
Net working cap to sales %50.670.7 71.6%  
Current ratio x1.72.5 68.7%  
Inventory Days Days5951 114.6%  
Debtors Days Days481,600 3.0%  
Net fixed assets Rs m7,02815,911 44.2%   
Share capital Rs m61141 43.5%   
"Free" reserves Rs m8,37524,092 34.8%   
Net worth Rs m8,43624,233 34.8%   
Long term debt Rs m202636 31.7%   
Total assets Rs m12,71231,829 39.9%  
Interest coverage x3.9-9.2 -42.3%   
Debt to equity ratio x00 91.0%  
Sales to assets ratio x0.40.4 85.8%   
Return on assets %-2.3-5.8 39.7%  
Return on equity %-4.0-8.3 47.9%  
Return on capital %2.0-6.4 -31.2%  
Exports to sales %43.369.7 62.1%   
Imports to sales %24.412.4 196.6%   
Exports (fob) Rs m1,9929,366 21.3%   
Imports (cif) Rs m1,1241,669 67.3%   
Fx inflow Rs m1,9929,366 21.3%   
Fx outflow Rs m1,1911,669 71.4%   
Net fx Rs m8017,697 10.4%   
CASH FLOW
From Operations Rs m-4,225-851 496.5%  
From Investments Rs m4,3032,028 212.2%  
From Financial Activity Rs m-184-813 22.6%  
Net Cashflow Rs m-105746 -14.1%  

Share Holding

Indian Promoters % 73.6 70.2 104.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 11.3 8.4%  
FIIs % 0.3 0.8 31.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 29.8 88.7%  
Shareholders   47,091 20,877 225.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs Unichem Lab

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs Unichem Lab Share Price Performance

Period Panacea Biotech Unichem Lab S&P BSE HEALTHCARE
1-Day -1.74% 1.90% 1.18%
1-Month -20.01% -5.40% -0.75%
1-Year 11.75% 78.12% 61.82%
3-Year CAGR -12.26% 16.06% 18.16%
5-Year CAGR -9.98% 19.87% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the Unichem Lab share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of Unichem Lab the stake stands at 70.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of Unichem Lab.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Unichem Lab paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of Unichem Lab.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.